Spruce Biosciences Analysis

Spruce Pink Sheet Analysis Notes

About 43.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.11. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Spruce Biosciences recorded a loss per share of 1.29. The entity had not issued any dividends in recent years. Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in Daly City, California. Spruce Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people.The quote for Spruce Biosciences is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Spruce Biosciences contact MPH MD at 415 655 4168 or learn more at https://sprucebio.com.

Spruce Biosciences Investment Alerts

Spruce Biosciences Upcoming and Recent Events

Spruce Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.32 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Spruce Biosciences's market, we take the total number of its shares issued and multiply it by Spruce Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Spruce Biosciences Insider Trading Activities

Spruce Biosciences Outstanding Bonds

Spruce Biosciences Predictive Daily Indicators

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Spruce Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Spruce shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Spruce Biosciences. By using and applying Spruce Pink Sheet analysis, traders can create a robust methodology for identifying Spruce entry and exit points for their positions.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

If you are still planning to invest in Spruce Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Spruce Biosciences' history and understand the potential risks before investing.